Stoke Therapeutics, Inc. (STOK)

NASDAQ: STOK · Real-Time Price · USD

11.63

-0.21 (-1.82%)

At close: Jun 27, 2025, 4:00 PM

11.65

+0.03 (0.22%)

After-hours: Jun 27, 2025, 7:09 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Antisense Oligonucleotide	8.78M	Log In
Antisense Oligonucleotide Growth	-29.22%	Log In

Revenue by Geography

Fiscal year is January - December.